Baxter plans $1B plasma operation in Georgia; Slovenia's Krka on hunt for buyout;

 @FiercePharma: More on Novartis' Q2 results, from Bloomberg. Consumer sales tumble 20% on plant closure. News | Follow @FiercePharma

> Baxter International ($BAX) is plotting a $1 billion plasma-processing complex in Atlanta, supported by collection facilities around the state of Georgia. Report

> Slovenian drugmaker Krka says it's looking to expand via acquisition and may announce a deal by year's end. Article

> To win regulatory approval for its buyout of Pfizer's ($PFE) nutrition unit, Nestlé may sell as much as $1.8 billion worth of the Pfizer unit's assets. Item

> The state of Nebraska says it will defy an FDA order to turn over its remaining supplies of sodium thiopental, an anesthetic used in executions. Story

> Sun Pharmaceutical Industries won FDA approval to sell a knockoff version of Eli Lilly's ($LLY) antipsychotic drug Zyprexa. News

> Shire ($SHPGY) was sanctioned by U.K. marketing watchdogs for claims it made on a website supporting its Gaucher's disease treatment Vpriv. More

> A study of anti-shingles vaccination concluded that the shot is safe and well-tolerated, with a low incidence of side effects. Report

Biotech News

 @FierceBiotech: Open source sizzles in biotech sphere. More | Follow @FierceBiotech

 @JohnCFierce: No surprise AZ is talking up brewing up more deals this year. No surprise they aren't even sticking to their disease focus. | Follow @JohnCFierce

 @RyanMFierce: FDA CIO Eric Perakslis told me that he wants to enable certain agency staff to work more virtually. He's giving more details at Bio-IT World 2012. | Follow @RyanMFierce

 @MarkHFierce: Seeking healthy fat? Then clone a sheep with the right nutrients genetically woven in--via ReutersArticle | Follow @MarkHFierce

> Amgen founding CEO George Rathmann dies at 84. News

> Biogen Idec builds blockbuster case for new MS drug BG-12. More

> AstraZeneca plots more pipeline deals. Article

> Merck KGaA shuttering Swiss complex, dispatching R&D to Boston. Story

Medical Devices News

 @FierceMedDev: Orthofix to sell sports-medicine unit for $157.5M | MarketWatchStory | Follow @FierceMedDev

> Boston Sci heralds Emerge launch in Europe, eyes U.S., other markets. Article

> Illumina results impress despite Roche drama. News

Biotech Research News

> Powerful protein halts DNA damage and may block tumors. More

> Johns Hopkins researchers find gene tied to CF secondary complication. Article

> Beyond stem cells: Scientists explore three new paths. Story

> Scientists successfully replicate synthetic DNA. Item

> Nanotech-boosted drug lessens cerebral palsy symptoms in rabbits. News

Pharma Manufacturing News

> Alli sale still held hostage by Roche GMP issues. Item

Life Technologies expands manufacturing in Scotland. More

> China seizes 77 million tainted drug capsules in crackdown. News

> Merck KGaA manufacturing dodges worst of reductions. Article

> Pfizer, J&J, Abbott facing shortages of crucial ingredients in Pakistan. Story

And Finally... What's the best time to get up? New alarm clocks will tell you. Report

Virtual Clinical Trials Summit

Virtual Clinical Trials Summit: The Premier Educational Event Focused on Decentralized Clinical Trials

In this virtual environment, we will look at current and future trends for ongoing virtual trials, diving into the many ways companies can improve patient engagement and trial behavior to enhance retention with a focus on emerging technology and harmonized data access across the clinical trial system.